Report
Dylan Van Haaften

From 3rd May, 2022 Voluntis will not be included in our research universe due to the proposed de-listing.

MedTech
End of coverage
From 3rd May, 2022 Voluntis will not be included in our research universe due to the proposed de-listing.
Underlying
Provider
Bryan Garnier
Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

Analysts
Dylan Van Haaften

Other Reports on these Companies
Other Reports from Bryan Garnier

ResearchPool Subscriptions

Get the most out of your insights

Get in touch